Pharma channel feed

Zol­gens­ma did­n't cause an in­fant death, AveX­is ex­ecs say as they spot­light long-term da­ta

6 years ago
R&D
Cell/Gene Tx

Sen­a­tors to FTC: Don't let the big Cel­gene and Al­ler­gan buy­outs hurt R&D and con­sumers

6 years ago
People
R&D

Af­ter tout­ing Gazy­va's po­ten­tial in lu­pus, Roche nabs 'break­through' ahead of PhI­II

6 years ago

Pop­u­la­tion phar­ma­co­ki­net­ics: Drug­mak­ers seek clar­i­ty and ad­di­tions to re­vised FDA guid­ance

6 years ago
FDA+

Scott Got­tlieb has a new board po­si­tion to add to the re­sume — and this one is fo­cused on a fa­vorite sub­ject

6 years ago
People

Pur­due Phar­ma files for bank­rupt­cy as first step in $10B opi­oid set­tle­ment

6 years ago

Ver­tex deal for Scot­land — no deal for Eng­land

6 years ago
FDA+

Roche's Tecen­triq ex­cels in an­oth­er lung can­cer study

6 years ago
R&D

Look out Alex­ion, Roche breaks out the de­tails on its ri­val rare CNS drug

6 years ago
R&D

In­di­an man­u­fac­tur­ing play­er Ju­bi­lant poach­es top No­var­tis BD ex­ec to run their new biotech start­up in Yard­ley, PA

6 years ago
People

CDER chief Janet Wood­cock has a mes­sage for phar­ma: 'It’s not work­ing, and it won’t work in the fu­ture'

6 years ago
People

Aca­dia de­clares ear­ly win on Nu­plazid de­men­tia study, stun­ning an­a­lysts and send­ing shares soar­ing

6 years ago
R&D

Boehringer In­gel­heim's Ofev wins FDA ap­proval for use in scle­ro­der­ma pa­tients

6 years ago
FDA+

Genen­tech reach­es set­tle­ment with Tai­wanese biotech ac­cused of steal­ing trade se­crets — but will keep su­ing ex-staffers

6 years ago

Roche boosts can­cer ap­provals in Eu­rope, push­ing for a big­ger slice of the I/O pie

6 years ago
R&D

The 'mind-blow­ing' R&D re­nais­sance in psy­che­del­ic meds finds a home at Johns Hop­kins

6 years ago
R&D

Mallinck­rodt preps a pos­si­ble bank­rupt­cy amid a mael­strom of opi­oid claims — re­port

6 years ago

The phar­ma in­dus­try's rep hits ab­solute. rock. bot­tom.

6 years ago

Ko­re­an bio­phar­ma ex­ec­u­tive in­dict­ed for al­leged­ly con­duct­ing il­le­gal tri­als on com­pa­ny re­searchers

6 years ago
People

US judge paves way for brand­ed and gener­ic opi­oid mak­ers to face land­mark Oc­to­ber tri­al

6 years ago
FDA+

As­traZeneca's di­a­betes drug Farx­i­ga cuts risk of CV death or wors­en­ing of heart fail­ure by 26% in land­mark study

6 years ago
R&D

A new PC­SK9 play­er draws rave re­views for in­clisir­an. Can a mar­ket­ing war with Am­gen be far be­hind?

6 years ago
R&D

Alex­ion hit by sur­prise in­ter partes re­view as Am­gen chal­lenges Soliris patents

6 years ago

Worst. biotech. deal. ever? Turns out Ab­b­Vie has plen­ty of com­pe­ti­tion for that ti­tle

6 years ago
Deals
R&D
First page Previous page 266267268269270271272 Next page Last page
A service from the Financial Times